TY - JOUR
T1 - Factors Associated With Self-Report Symptom Screening Adherence in Pediatric Cancer Patients
AU - Dupuis, L. Lee
AU - Vettese, Emily
AU - Aftandilian, Catherine
AU - Agarwal, Vibhuti
AU - Baggott, Christina
AU - Bradfield, Scott M.
AU - Crellin-Parsons, Nicole
AU - Freyer, David R.
AU - Kelly, Kara M.
AU - King, Allison A.
AU - Kyono, Wade
AU - Nagasubramanian, Ramamoorthy
AU - Orgel, Etan
AU - Roth, Michael E.
AU - Sherani, Farha
AU - Yu, Lolie
AU - Grimes, Allison C.
AU - Beauchemin, Melissa P.
AU - Klesges, Lisa M.
AU - Tomlinson, George A.
AU - Sung, Lillian
N1 - Publisher Copyright: © 2025 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.
PY - 2025/7
Y1 - 2025/7
N2 - Introduction: Objective was to describe the association between baseline characteristics and the number of Symptom Screening in Pediatrics Tool (SSPedi) assessments completed over an 8-week period. Methods: This was a sub-analysis of a cluster randomized controlled trial among 10 sites that were randomized to the intervention group. Participants were English- or Spanish-speaking pediatric patients 8–18 years of age newly diagnosed with cancer. Participants were prompted to complete SSPedi three times weekly for 8 weeks. The outcome was the number of SSPedi assessments completed during the 8-week period. Factors associated with the number of assessments were determined using mixed effects Poisson regression. Results: At the 10 intervention sites, 216 patients were included in the analysis. Among these participants, 129 (59.7%) were male, 112 (51.9%) were white, and 83 (38.4%) were Hispanic. The number of SSPedi assessments was significantly higher for participants 11–14 years (rate ratio (RR) 1.13, 95% confidence interval (CI) 1.02–1.25) and 15–18 years (RR 1.15, 95% CI 1.04–1.27) compared to 8–10 years. Participants completed more SSPedi assessments if they were Asian compared to white (RR 1.27, 95% CI 1.10–1.46), non-Hispanic compared to Hispanic (RR 1.15, 95% CI 1.04–1.28) and from families with a household income ≥$60,000 (RR 1.12, 95% CI 1.03–1.21). Participants completed fewer SSPedi assessments if they had solid tumors compared to leukemia (RR 0.91, 95% CI 0.84–0.99). Conclusion: Adherence to three-times weekly SSPedi varied by age, race, ethnicity, cancer diagnosis, and family income. This information may facilitate interventions to support routine symptom screening in clinical practice. Trial Registration: NCT04614662.
AB - Introduction: Objective was to describe the association between baseline characteristics and the number of Symptom Screening in Pediatrics Tool (SSPedi) assessments completed over an 8-week period. Methods: This was a sub-analysis of a cluster randomized controlled trial among 10 sites that were randomized to the intervention group. Participants were English- or Spanish-speaking pediatric patients 8–18 years of age newly diagnosed with cancer. Participants were prompted to complete SSPedi three times weekly for 8 weeks. The outcome was the number of SSPedi assessments completed during the 8-week period. Factors associated with the number of assessments were determined using mixed effects Poisson regression. Results: At the 10 intervention sites, 216 patients were included in the analysis. Among these participants, 129 (59.7%) were male, 112 (51.9%) were white, and 83 (38.4%) were Hispanic. The number of SSPedi assessments was significantly higher for participants 11–14 years (rate ratio (RR) 1.13, 95% confidence interval (CI) 1.02–1.25) and 15–18 years (RR 1.15, 95% CI 1.04–1.27) compared to 8–10 years. Participants completed more SSPedi assessments if they were Asian compared to white (RR 1.27, 95% CI 1.10–1.46), non-Hispanic compared to Hispanic (RR 1.15, 95% CI 1.04–1.28) and from families with a household income ≥$60,000 (RR 1.12, 95% CI 1.03–1.21). Participants completed fewer SSPedi assessments if they had solid tumors compared to leukemia (RR 0.91, 95% CI 0.84–0.99). Conclusion: Adherence to three-times weekly SSPedi varied by age, race, ethnicity, cancer diagnosis, and family income. This information may facilitate interventions to support routine symptom screening in clinical practice. Trial Registration: NCT04614662.
KW - adherence
KW - oncology
KW - pediatric
KW - symptom screening
UR - https://www.scopus.com/pages/publications/105011261999
U2 - 10.1002/cam4.71053
DO - 10.1002/cam4.71053
M3 - Article
C2 - 40686265
SN - 2045-7634
VL - 14
JO - Cancer Medicine
JF - Cancer Medicine
IS - 14
M1 - e71053
ER -